Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms

Tzung J Hwang1, Donna L Masterman, Freddy Ortiz

  • 1Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, USA.

Insights

Mild cognitive impairment (MCI) often includes neuropsychiatric symptoms like apathy and mood changes. These symptoms differ between MCI and Alzheimer's disease (AD), with psychosis more common in AD.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) is a transitional state preceding Alzheimer's disease (AD).
  • Neuropsychiatric features of amnestic MCI require further comprehensive study.
  • Previous research focused on neurobiological and neuroimaging aspects of MCI.

Purpose of the Study:

  • To define neuropsychiatric features in amnestic MCI.
  • To compare these features with mild AD and normal controls.
  • To investigate the prevalence of specific neuropsychiatric symptoms in MCI.

Main Methods:

  • A preliminary study using the Neuropsychiatric Inventory (NPI).
  • Assessment of 28 MCI patients, 124 mild AD patients, and 50 normal controls.
  • Comparison of individual NPI symptom subscores and total NPI scores between groups.

Main Results:

  • MCI patients frequently exhibited neuropsychiatric symptoms, notably dysphoria, apathy, irritability, and anxiety.
  • Significant differences were found in apathy, dysphoria, irritability, anxiety, agitation, and aberrant motor behavior between MCI and control groups.
  • Delusions were less common in MCI than in mild AD; total NPI scores differed significantly between MCI and controls but not between MCI and mild AD.

Conclusions:

  • Amnestic MCI is linked to significant neuropsychiatric symptoms, particularly mood disturbances and apathy.
  • Psychotic symptoms are more prevalent in early AD than in MCI.
  • These findings require validation through longitudinal, community-based research.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...